150 related articles for article (PubMed ID: 21821808)
1. Analysis of the effect of the bovine adenosine triphosphate-binding cassette transporter G2 single nucleotide polymorphism Y581S on transcellular transport of veterinary drugs using new cell culture models.
Real R; González-Lobato L; Baro MF; Valbuena S; de la Fuente A; Prieto JG; Alvarez AI; Marques MM; Merino G
J Anim Sci; 2011 Dec; 89(12):4325-38. PubMed ID: 21821808
[TBL] [Abstract][Full Text] [Related]
2. Effect of bovine ABCG2 polymorphism Y581S SNP on secretion into milk of enterolactone, riboflavin and uric acid.
Otero JA; Miguel V; González-Lobato L; García-Villalba R; Espín JC; Prieto JG; Merino G; Álvarez AI
Animal; 2016 Feb; 10(2):238-47. PubMed ID: 26510964
[TBL] [Abstract][Full Text] [Related]
3. Novel in vitro systems for prediction of veterinary drug residues in ovine milk and dairy products.
González-Lobato L; Real R; Herrero D; de la Fuente A; Prieto JG; Marqués MM; Alvarez AI; Merino G
Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2014; 31(6):1026-37. PubMed ID: 24679113
[TBL] [Abstract][Full Text] [Related]
4. The bovine ATP-binding cassette transporter ABCG2 Tyr581Ser single-nucleotide polymorphism increases milk secretion of the fluoroquinolone danofloxacin.
Otero JA; Real R; de la Fuente Á; Prieto JG; Marqués M; Álvarez AI; Merino G
Drug Metab Dispos; 2013 Mar; 41(3):546-9. PubMed ID: 23230133
[TBL] [Abstract][Full Text] [Related]
5. The ABCG2 Efflux Transporter in the Mammary Gland Mediates Veterinary Drug Secretion across the Blood-Milk Barrier into Milk of Dairy Cows.
Mahnke H; Ballent M; Baumann S; Imperiale F; von Bergen M; Lanusse C; Lifschitz AL; Honscha W; Halwachs S
Drug Metab Dispos; 2016 May; 44(5):700-8. PubMed ID: 26956640
[TBL] [Abstract][Full Text] [Related]
6. Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment.
Otero JA; Barrera B; de la Fuente A; Prieto JG; Marqués M; Álvarez AI; Merino G
J Dairy Sci; 2015 Jan; 98(1):312-7. PubMed ID: 25465626
[TBL] [Abstract][Full Text] [Related]
7. Effect of bovine ABCG2 Y581S polymorphism on concentrations in milk of enrofloxacin and its active metabolite ciprofloxacin.
Otero JA; García-Mateos D; de la Fuente A; Prieto JG; Álvarez AI; Merino G
J Dairy Sci; 2016 Jul; 99(7):5731-5738. PubMed ID: 27157572
[TBL] [Abstract][Full Text] [Related]
8. Role of ABCG2 in Secretion into Milk of the Anti-Inflammatory Flunixin and Its Main Metabolite: In Vitro-In Vivo Correlation in Mice and Cows.
Garcia-Mateos D; Garcia-Lino AM; Alvarez-Fernandez I; Blanco-Paniagua E; de la Fuente A; Alvarez AI; Merino G
Drug Metab Dispos; 2019 May; 47(5):516-524. PubMed ID: 30858238
[TBL] [Abstract][Full Text] [Related]
9. Natural allelic variants of bovine ATP-binding cassette transporter ABCG2: increased activity of the Ser581 variant and development of tools for the discovery of new ABCG2 inhibitors.
Merino G; Real R; Baro MF; Gonzalez-Lobato L; Prieto JG; Alvarez AI; Marques MM
Drug Metab Dispos; 2009 Jan; 37(1):5-9. PubMed ID: 18824523
[TBL] [Abstract][Full Text] [Related]
10. Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: interaction with ivermectin.
Real R; Egido E; Pérez M; González-Lobato L; Barrera B; Prieto JG; Alvarez AI; Merino G
J Vet Pharmacol Ther; 2011 Aug; 34(4):313-21. PubMed ID: 20950350
[TBL] [Abstract][Full Text] [Related]
11. Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter.
Barrera B; González-Lobato L; Otero JA; Real R; Prieto JG; Álvarez AI; Merino G
Vet J; 2013 Nov; 198(2):429-36. PubMed ID: 23981352
[TBL] [Abstract][Full Text] [Related]
12. Assessment of ABCG2-mediated transport of xenobiotics across the blood-milk barrier of dairy animals using a new MDCKII in vitro model.
Wassermann L; Halwachs S; Baumann D; Schaefer I; Seibel P; Honscha W
Arch Toxicol; 2013 Sep; 87(9):1671-82. PubMed ID: 23652544
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: effect on plasma and milk levels of danofloxacin in sheep.
Perez M; Otero JA; Barrera B; Prieto JG; Merino G; Alvarez AI
Vet J; 2013 May; 196(2):203-8. PubMed ID: 23083838
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer resistance protein (BCRP/ABCG2) transports fluoroquinolone antibiotics and affects their oral availability, pharmacokinetics, and milk secretion.
Merino G; Alvarez AI; Pulido MM; Molina AJ; Schinkel AH; Prieto JG
Drug Metab Dispos; 2006 Apr; 34(4):690-5. PubMed ID: 16434544
[TBL] [Abstract][Full Text] [Related]
15. N-(4-[2-(1,2,3,4-tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]-phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide (GF120918) as a chemical ATP-binding cassette transporter family G member 2 (Abcg2) knockout model to study nitrofurantoin transfer into milk.
Wang L; Leggas M; Goswami M; Empey PE; McNamara PJ
Drug Metab Dispos; 2008 Dec; 36(12):2591-6. PubMed ID: 18799806
[TBL] [Abstract][Full Text] [Related]
16. Determination of functional ABCG2 activity and assessment of drug-ABCG2 interactions in dairy animals using a novel MDCKII in vitro model.
Wassermann L; Halwachs S; Lindner S; Honscha KU; Honscha W
J Pharm Sci; 2013 Feb; 102(2):772-84. PubMed ID: 23192864
[TBL] [Abstract][Full Text] [Related]
17. The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP.
Barrera B; Otero JA; Egido E; Prieto JG; Seelig A; Álvarez AI; Merino G
Antimicrob Agents Chemother; 2012 Jul; 56(7):3535-43. PubMed ID: 22508302
[TBL] [Abstract][Full Text] [Related]
18. A novel MDCKII in vitro model for assessing ABCG2-drug interactions and regulation of ABCG2 transport activity in the caprine mammary gland by environmental pollutants and pesticides.
Halwachs S; Wassermann L; Honscha W
Toxicol In Vitro; 2014 Apr; 28(3):432-41. PubMed ID: 24389113
[TBL] [Abstract][Full Text] [Related]
19. The gut microbiota ellagic acid-derived metabolite urolithin A and its sulfate conjugate are substrates for the drug efflux transporter breast cancer resistance protein (ABCG2/BCRP).
González-Sarrías A; Miguel V; Merino G; Lucas R; Morales JC; Tomás-Barberán F; Alvarez AI; Espín JC
J Agric Food Chem; 2013 May; 61(18):4352-9. PubMed ID: 23586460
[TBL] [Abstract][Full Text] [Related]
20. The breast cancer resistance protein (BCRP/ABCG2) affects pharmacokinetics, hepatobiliary excretion, and milk secretion of the antibiotic nitrofurantoin.
Merino G; Jonker JW; Wagenaar E; van Herwaarden AE; Schinkel AH
Mol Pharmacol; 2005 May; 67(5):1758-64. PubMed ID: 15709111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
